Drug Type Small molecule drug |
Synonyms |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Sclerosis | Preclinical | China | 12 Oct 2022 | |
Myasthenia Gravis | Preclinical | China | 12 Oct 2022 | |
Neuromyelitis Optica | Preclinical | China | 12 Oct 2022 | |
Psoriasis | Preclinical | China | 12 Oct 2022 | |
Rhinitis, Allergic | Preclinical | China | 12 Oct 2022 | |
Sjogren's Syndrome | Preclinical | China | 12 Oct 2022 | |
Systemic Lupus Erythematosus | Preclinical | China | 12 Oct 2022 |